Diagnostic Testing Procedures in Endoscopy Department

Size: px
Start display at page:

Download "Diagnostic Testing Procedures in Endoscopy Department"

Transcription

1 Diagnostic Testing Procedures in Endoscopy Department V September 12 Diagnostic Testing Procedures in the Endoscopy Department Page 1 of 17

2 Table of Contents 1. Introduction Purpose of this Policy Scope Definitions / Glossary Ownership and Responsibilities (Duties) Role of the Managers Role of the Diagnostics and Therapeutics Divisional Governance Management Board Role of Individual Staff Role of Governance Leads Standards and Practice Content Diagnostic tests provided by the service How diagnostic testing procedures are risk assessed Measures that need to be in place for the diagnostic test to enable any preparation of the patient (e.g. fasting) required Identifying the process for ensuring that informed consent is obtained prior to a diagnostic test How the diagnostic test is requested Systems in place to ensure that the sample(s) are correctly identified and labelled, prepared and transported Identifying where it is appropriate to request an acknowledgement from the receiving laboratory for specific samples Ensuring that diagnostic tests are received within agreed time frames How the clinician treating the patient is informed of the result, including timescales How the patient is informed of the result, including timescales Actions to be taken by the clinician, including timescales How the minimum requirements for How the organisation monitors compliance Dissemination and Implementation (including education & training) Monitoring compliance and effectiveness Updating and Review Equality and Diversity Equality Impact Assessment... 12

3 Appendix 1. Governance Information Appendix 2.Initial Equality Impact Assessment Screening Form Page 2 of 17

4 1. Introduction Diagnostic (Endoscopy) testing information supports many clinical decisions both in the identification of new conditions and the monitoring and treatment of existing ones. As such it sits within the overall patient clinical pathway. The diagnostic pathway begins when a test is indicated such that a request is generated, progresses via the diagnostic process and ends when a report is received by the requester and acted upon. Failures at any point in this pathway may lead to delays in the care of the patient, sometimes with serious clinical consequences. 2. Purpose of this Policy This policy sets out an approved documented process whereby the risks associated with diagnostic testing procedures within Endoscopy (Gastroenterology) are managed through the provision of local policies and procedures which are implemented and monitored. It has been developed to ensure these risks are minimised through the provision of clear information, guidance and expectation. No patient s treatment should be delayed because of delays in the availability of Diagnostic information and the objective of this document is to ensure that this does not happen, recognising that communication problems are often the root of such delays; there is an absolute need for clear pathways that identify how, when and to whom the results should be communicated. This policy is aimed at those who provide and those who use the Endoscopy services. 3. Scope This policy applies to all those who request Endoscopy diagnostic tests and those who receive, process or need to act on the results of these. 4. Definitions / Glossary NHSLA: National Health Service Litigation Authority CITS: Cornwall IT Services CRIS: Clinical Radiology Information System DBMS: Database Management section within CITS GP: General Practitioner MAXIMS: Electronic clinical record system designed by IMS (Irish Medical Systems) PACS: Picture Archive Communication System RCHT: Royal Cornwall Hospitals NHS Trust 5. Ownership and Responsibilities (Duties) 5.1. The strategic and operational roles responsible for the development, management and implementation of the policy are shown below Role of the Managers Line managers are responsible for: Conducting stringent recruitment checks to ensure that only appropriately qualified and registered staff undertake and authorise test results and ongoing checks of professional registration Ongoing checks of Training & competence to perform those tests within the scope of activity of individual staff Page 3 of 17

5 Ensuring that staff follow those processes and procedures described in the Standards and Practice section relevant to the part they play in the diagnostic pathway Role of the Medicine and Emergency Department Divisional Governance Management Board The Medicine and Emergency Department Divisional Governance Management Board is responsible for the development, approval and communication of this policy and monitoring compliance with it Role of Individual Staff 5.5. The diagnostic pathway begins when a request is generated and any samples required are taken; it progresses via the diagnostic testing process and ends when a report is received by the requester and acted upon. Various healthcare staff are involved in this pathway including Doctors, Nurses, Healthcare Assistants/Support workers and Professions Allied to Medicine (Biomedical Scientists, Radiographers etc.) Ward based Administrative staff have an important role in ensuring that, for paper based reporting systems, all results are communicated to the Clinical staff in charge of the patient Administrative staff in Endoscopy (Gastroenterology) also have a role to play in ensuring imaging appointments are booked and appropriate preparation instigated in accordance with agreed operating policies Unit based Administrative staff ensure that any paper reports are despatched in a timely manner All staff members are responsible for: Being aware of this policy and any documents referred to within it pertaining to their part in the diagnostic pathway. Adhering to any requirements described within this policy and documents described in the standards and practice section pertaining to their role in the diagnostic pathway Role of Governance Leads It is the responsibility of governance Leads to ensure that processes are in place within specialties which ensure that every Endoscopy result requested from within RCHT is acted upon. 6. Standards and Practice 6.1. Content The content of this section takes account of the the overarching Trust-wide policy and specific requirements of the endoscopy department and is used to provide details and information describing the practices, systems, and processes staff are expected to follow. Page 4 of 17

6 6.2. Diagnostic tests provided by the service The Endoscopy Service provides a range of endoscopy procedures dependant on clinical need, the exact procedure id determined in discussion with the referring consultant How diagnostic testing procedures are risk assessed 6.4. Departments need to focus on the degree of intervention required, the consequence of missed diagnosis and the impact for the trust. Information sources include a trawl of the complaints, claims and incidents data to see if there are common themes as this would also indicate an area of increased risk for the organisation Diagnostic testing procedures are evaluated at the time of introduction (e.g. to check that the procedure is fit for purpose ). Risk assessment tends to be reactive to changes such as the introduction of new guidelines or equipment or changes to existing equipment (e.g. with age) which require that the current level of risk is reassessed All endoscopy examinations are vetted by a practitioner and a decision made to proceed on the risk v. clinical benefit. (Surgery do not currently vet 2WW referrals, they go straight to a 2WW clinic) This applies to all imaging examinations but is particularly pertinent where there is a high radiation dose associated with the examination Measures that need to be in place for the diagnostic test to enable any preparation of the patient (e.g. fasting) required Where these are required this will be indicated in User guides/requesting information or specific information provided for patients Identifying the process for ensuring that informed consent is obtained prior to a diagnostic test Consent for investigations is obtained by the test requester. The reader is referred to their Organisation s consent policy How the diagnostic test is requested It is important that requests are generated, received and processed correctly in order for the diagnostic process to be initiated in the first place Requesting Pathology investigations is currently done using completed paper request forms/cards. The process is described in the Pathology Specimen Acceptance Policy, which gives details of information which must be provided on request forms and specimens before they can be accepted, and the Pathology User Guide which includes information on how to make urgent requests. Both documents are available on the Document Library.. Control of who may request Pathology tests is via the allocation/activation of requester codes. These are issued via CITS after checking with Pathology staff (including Pathology IT Manager). Requests received from an unrecognised requester will be queried by the Laboratory. Users receiving results inappropriately requested in their name must query this with the Laboratory. Page 5 of 17

7 6.12. It is the responsibility of the requesting Clinician to complete the request form accurately clearly indicating the requesting Clinician The professional expectation is that anyone requesting a test should have the training, experience and authority to explain the result to the patient. The laboratory has a duty to carry out reasonable tests on the assumption that they have been legitimately requested. Some specialised tests may only be performed if requested by a Consultant and some require approval by a Consultant Haematologist During 2012/13 Pathology will move to electronic requesting for RCHT patients A Protocol for Referral to Endoscopy informs referrers of their legal responsibilities when requesting Endoscopy (BSG Guidelines), highlights the Trust s referral criteria which provide the referrer with guidance on making appropriate Endoscopy requests and provides the referrer with access to relevant information and training. Medical practitioners and suitably qualified nurses are deemed qualified to be referrers as a result of their overall training; non-medical referrers have to provide evidence of specific training. The protocol states who can refer patients for Endoscopy procedures and any authorisation requirements e.g. of non - medical referrers (e.g. Emergency Nurse Practitioners and SSP (BCS)). This document is available on the Document Library. All referrals are 'justified' by a suitably qualified Practitioner There is a specific protocol for the approval of non-medical referrers which is on the document library All Endoscopy requests are made in writing either paper based (GP requests) or electronic via MAXIMS (RCHT Clinicians planned for 2012), the content of the referral is detailed within the Endsocopy referral protocol and is in keeping with BSG guidelines Systems in place to ensure that the sample(s) are correctly identified and labelled, prepared and transported Pathology has a sample acceptance policy which describes sample and request form labelling and considerations regarding the integrity of samples. Sample transport arrangements are described in the Pathology User guide. Both documents are on the Documents Library Identifying where it is appropriate to request an acknowledgement from the receiving laboratory for specific samples Where results are required within an accelerated timescale or samples are of an irretrievable or labile nature or analysis is only carried out on a scheduled basis, requesters may wish to contact labs to ensure that samples have been received Ensuring that diagnostic tests are received within agreed time frames It is the responsibility of the requester to ensure that samples are delivered or patients present for testing within any cut-off times quoted in published User information or Policies. Page 6 of 17

8 6.21. How the clinician treating the patient is informed of the result, including timescales Endoscopy results are available electronically to RCHT clinicians (via SCORPIO) and GP s are faxed Pathology results are available electronically to both RCHT Gastroenterologists (via Winpath and MAXIMS) and GP s (via GP Link); paper copies are also sent to RCHT clinicians pending upgrades to MAXIMS functionality. (Gastroenterologists access Scorpio to review results, this is not possible for non gastroenterologists.) When full functionality is achieved, Pathology results will be viewed in MAXIMS and the user will have the opportunity to: Close the result without changing the status (an audit trails is kept though) Mark the result as seen but needs review. It will be possible to allocate this to another viewer. Mark the report as checked It will be possible to add an annotation to the result in any of these circumstances. This will obviously be important when the result is marked for needing reviewed by another clinician Every result will have to be finally marked off as checked at some point There will be several ways to reach results. You can either access the Patient results through the patient context and this is the method by which we anticipate results will be marked off whilst an inpatient. The patient record will be opened, e.g. during a ward round, all new results viewed and signed off at that point. When the patient is discharged the results should be checked again to ensure they are all signed off. Outstanding results will be found in the outpatient new results screen of the consultant who is looking after the patient, when the patient is discharged For outpatients it is anticipated that the results will be viewed through a new results screen, which is patient independent and populated with results as they appear for any patient under the care of that responsible clinician Pathology analytical Standard Operating Procedures (SOP) include a section Reporting of results, reference interval, critical values and interpretation. Pathology reporting arrangements are described in SOP [PA G MP ALL PATHREPORT ]; separate SOPs describe arrangements for escalating and recording urgent/unexpected/significantly abnormal results which affect the immediate management of the patient e.g. by telephoning (excluding Histopathology). Turnaround times for individual tests are listed in the Pathology User Guide (Table 1) The reporting of Endoscopy procedures undertaken by the Endoscopists Team is described in Protocol for the Reporting of Clinical Imaging Examinations and Procedures which includes a section (8) on Communication of findings including Urgent / Unexpected Significant Findings and Safety Net procedures for Non-critical Findings and reporting targets. Page 7 of 17

9 6.31. The Ward Telephoned Results policy describes the process and actions to be followed by both the Laboratory and Ward when results are telephoned from the lab to Wards The process by which results are captured for review at MDT meetings must be robust, and procedures determined locally by the meeting organiser in agreement with the Laboratory or Endoscopy, to ensure that serious results e.g. new malignancies are reviewed How the patient is informed of the result, including timescales Patients must be made aware of the reason for tests being requested and the approximate timescale and communication method for availability of the results so that they may request an update on results as necessary. Results which have significant implications for the patient must be discussed with them in the appropriate timescale There is an expectation that patients are informed of results by the requesting clinician in a timely fashion; this includes any tests added on by the laboratory in order to achieve a definitive diagnosis. It is the responsibility of the requester to consider how, when and what to tell the patient The mechanisms and timescales for informing patients of results are the responsibility of the requesting clinician but may include, according to the nature of the test, availability of result and the significance of the result: Telling patients Writing to patients Discussing with patients at Outpatient or pre-op assessment clinics Writing to their GP Accessing a website (Renal patients) Telephone call (e.g. for cancer results) with consent of patient Adding to discharge summary Every opportunity should be taken to check for/flag outstanding results including at hospital discharge, Outpatient and GP appointments Actions to be taken by the clinician, including timescales Actions to be taken on receipt of telephoned results are described in the Trust s Ward Telephoned Results procedure The person receiving the results should ensure the results are brought to the attention (urgently if necessary) of the clinical team currently caring for the patient. Results should be reviewed by a person with clinical responsibility for the patient who is able to interpret the results and ensure a management plan is recorded as required. Processes must be in place for notification of results to patients The requesting Consultant will take responsibility for ALL investigations requested by them or in their name, but the responsibility for signing off a result can be appropriately delegated. In MAXIMS results default to going back to the Consultant who is in charge of the patient, under whose name the tests are Page 8 of 17

10 requested. However the person who actually requested the test can also search under their name and find the result The requesting Clinician is responsible for reviewing any urgent results requested during their shift, and passing the responsibility on if they finish their shift. For those tests that are requested but the patient has moved on to another area when the test is done or the result is available, responsibility for the results passes to the clinician responsible for the patient in that area It is incumbent on the responsible clinician to ensure that he or she personally checks the reporting systems on a regular basis for the investigation results and then acts on the information within the report with the necessary degree of urgency. If they are unable to do this they must hand the responsibility over to a colleague. Failure to do this may put patients at risk By and large inpatient results will be signed off by the team who is currently looking after the patient, independent of where the request was made. If this doesn't happen it will still fall to the Consultant under whose name the tests were originally requested to sign-off the results. Outpatient results will usually be signed of by the Consultant under whose name the test was requested or a designated member of their team Safety net procedures must be established by requesters to ensure all results are acted upon in a timely manner and high risk diagnoses and results (e.g. cancer) are not inadvertently missed. The procedure must take account of patients moving from area to area within a hospital and being discharged before results are received Minimum Recording Requirements Requesting Requests received by Pathology are recorded on the Winpath Computer system. Requests received by Imaging are recorded on the CRIS system Informing the clinician At present there is no record of clinicians being informed of the result other than the printing of reports and those which are telephoned. Practices vary as to what is recorded by the requester and where. When full functionality is achieved in MAXIMS every result will have to be finally marked off as checked Communication of test results between the results provider and clinical staff involved with the care of the patient must be recorded in Pathology or Endoscopy systems including the name of any individual staff results are given to (e.g. by telephone) Communication of test results between clinical staff who have received results and other healthcare staff or patients must be recorded in the notes Informing the patient Records are kept of any written correspondence with the patient or their Doctor in the notes. Records are kept of discussions (in person or over the telephone) in the notes Actions taken Page 9 of 17

11 6.55. Actions taken are documented in the notes. It will be possible to add an annotation to the result in MAXIMS When recording results within the patient s record the minimum information which must be included is: Forename and surname NHS/Hospital number For unknown patients a coded identifier may be used Test or procedure Date and time investigation was performed (Imaging) or sample taken (Pathology) Interpretive comments made/conclusion reached may be recorded The method of communication of the actions must be recorded, i.e. face to face contact, phone call, letter, , fax, etc Hospital discharge summaries should record confirmed diagnosis and any outstanding investigations How the organisation monitors compliance How the clinician treating the patient is informed of the result, including timescales For hospital laboratory electronic reports, the Trusts Integration Engine has automatic monitoring which s the Database Management Section team in CITS day or night if any delays are detected The Maxims system is also monitored throughout the day by a separate team in CITS. The Maxims software application has an inbuilt interface that monitors incoming HL7 messages from various other applications such as PAS, Winpath (pathology results only at the moment) CRIS (request status updates and results). The only outgoing HL7 messages from Maxims currently are Radiology order requests which feed through to CRIS Transmission of electronic laboratory reports to GP s is checked (report has successfully arrived at the GP practice, with no errors in the transmission, and is available in their system) as a minimum twice daily by the Database Management Section team in CITS. Unacknowledged reports are automatically retransmitted but this is quite rare now It is difficult to audit how many results have been looked at with the current systems of informing clinicians of results. Once we move to using Maxims for acknowledgement we would expect everybody to look at their results on the system and not use any of the other systems. A comprehensive report will be carried out monthly to ensure that all results are looked at Reporting timescales are monitored on a weekly or monthly basis for selected tests/procedures. A quarterly diagnostic census checks for any Pathology tests which have not been reported within 6 weeks How the patient is informed of the result, including timescales Page 10 of 17

12 6.67. Requesters should check that they have received all reports back (allowing for diagnostic turnaround times) and that results have been correctly documented and acted upon (including telephoned reports/results) and patients informed as appropriate on an ongoing basis as part of their safety net procedures Requests will be monitored regularly for data omissions (paper), errors (e.g. wrong patient requested) or incorrect transfer to Radiology or Pathology Information Systems. Imaging monitoring arrangements include a weekly check report for orders from MAXIMS going onto the appointment list in CRIS; assigning to clinical imaging reporting areas is checked weekly. Pathology requests are audited annually with ongoing review of DATIX incidents Pathology incident reports are analysed annually for Pathology reports which are sent to the wrong location (e.g. due to computer registration errors or postal errors) Endoscopy incident reports are reviewed 2-monthly for trends in reporting errors and, where these occur, incidents are investigated appropriately, corrective actions are taken and lessons disseminated through the directorate s governance structure (Governance Group, Directorate meeting and Operational meetings), or Trust structures via the Divisional Quality Group Outstanding work lists, including delays in the return of results of work referred to other laboratories, are monitored in Laboratories on an ongoing basis Endoscopy results from outsourced providers are transferred to the RCHT WebPACS and CRIS so that these are electronically available to referring clinicians and those directly affected in the patient s ongoing clinical care The format and contents of reports leaving the laboratory (electronically or on paper) should be checked annually The format and contents of reports received (electronic or paper) should be checked on an ongoing basis and errors notified to the Pathology or Imaging Departments without delay Telephoned Pathology reports should be checked annually. 7. Dissemination and Implementation (including education & training) The document will be placed on the Cornwall & Isles of Scilly Health Community Documents Library with notification of all users via . It will also appear on the Pathology and Clinical Imaging A-Z of Services Intranet pages. 8. Monitoring compliance and effectiveness Element to be monitored 1. Informing the clinician treating the patient of the result; ensuring they are looked at/acknowledged choose those tests assessed as highest risk 2. Reporting timescales 3. Acting on, documenting & Informing the patient of the result Page 11 of 17

13 Lead Tool Frequency Reporting arrangements choose those tests assessed as highest risk 4. Others see 6.59 onwards (as relevant) - are monitored by internal audit systems within the Endoscopy s from where evidence is available. 1. Endoscopy Lead 1. SCORPIO 1. Weekly/Monthly/Quarterly (depending on test/department) Reports will be reviewed by Governance and Management Committees within Divisional Quality & Learning Group. Each report should contain a summary and action points to enable these to be readily identified; these should be discussed and recorded in meeting minutes. The lead or committee is expected to read and interrogate the report to identify deficiencies in the system and act upon them. Acting on recommendations and Lead(s) Change in practice and lessons to be shared The Committee which reviews the report will delegate recommendations and action planning, for any or all deficiencies and recommendations within reasonable timeframes, to the appropriate committee, department or lead. Required actions will be identified and completed in a specified timeframe. Required changes to practice will be identified and actioned within the minimum achievable timescale. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders. 9. Updating and Review This policy will be reviewed every two years or sooner if circumstances suggest this may be necessary. 10. Equality and Diversity 10.1.This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement Equality Impact Assessment A completed Initial Equality Impact Assessment Screening Form is at Appendix 2. Page 12 of 17

14 Appendix 1. Governance Information Document Title Endoscopy Procedures in Gastroenterology (Medicine and Emergency Department Division) Date Issued/Approved: 24th September 2012 Date Valid From: 24th September 2012 Date Valid To: 1 st September 2015 Directorate / Department responsible (author/owner): Endoscopy Lead and Governance lead in Medicine and Emergency Department Division Contact details: Brief summary of contents Suggested Keywords: Target Audience Executive Director responsible for Policy: Date revised: This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes This policy sets out an approved documented process whereby the risks associated with diagnostic testing procedures in Endoscopy are managed. Diagnostic Test, Pathology, Clinical Imaging. RCHT PCT CFT Medical Director First issue New Document Medicine and Emergency Department Divisional Governance Management Board. Divisional Quality & Learning Group Rowena Green Dr Paul Fortun, Specialty Lead Endoscopy Name and Post Title of additional signatories Signature of Executive Director giving approval Dr Bryson Pottinger, Specialty Director Laboratory Medicine & Haematology Dr Joe Mathew, Specialty Director Histopathology Sally Rowe, Divisional Director, Diagnostics & Therapeutics {Original Copy Signed} Page 13 of 17

15 Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents: Training Need Identified? Internet & Intranet Clinical / Gastroenterology Intranet Only NHSLA Standard 5 Criterion 7: Diagnostic Testing Procedures Safer Practice Notice 16, February 2007 An Organisation-wide Policy for the Management of Diagnostic Testing Procedures Ward Telephoned Results procedure. No Version Control Table Date Version No Summary of Changes Changes Made by (Name and Job Title) 24 July 12 V1.0 Initial Issue 17 Sept 12 V 2.0 Comments Amanda Tullett and Tim Mumford Paul Fortun, Lisa Ivers, Tim Mumford All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 14 of 17

16 Appendix 2.Initial Equality Impact Assessment Screening Form Name of service, strategy, policy or project (hereafter referred to as policy) to be assessed: Endoscopy Procedures Directorate and service area: Medicine Is this a new or existing Procedure? and ED New Name of individual completing Telephone: assessment: AT and TM 1. Procedure Aim* Sets out an approved documented process whereby the risks associated with diagnostic testing procedures are managed through the provision of local policies which are implemented and monitored. 2. Procedure Objectives* The risks associated with diagnostic testing procedures are minimised; compliance with NHSLA Standard 5 Criterion 7: Diagnostic Testing Procedures is achieved. 3. Procedure intended To ensure that the diagnostic process contributes the Outcomes* maximum benefit to the treatment of patients. 4. How will you measure the outcome? 5. Who is intended to benefit from the Procedure? 6a. Is consultation required with the workforce, equality groups etc. around this procedure? As described in Sections & 8. All patients No b. If yes, have these groups been consulted? c. Please list any groups who have been consulted about this procedure. *Please see Glossary 7. The Impact Please complete the following table using ticks. You should refer to the EA guidance notes for areas of possible impact and also the Glossary if needed. Where you think that the policy could have a positive impact on any of the equality group(s) like promoting equality and equal opportunities or improving relations within equality groups, tick the Positive impact box. Where you think that the policy could have a negative impact on any of the equality group(s) i.e. it could disadvantage them, tick the Negative impact box. Page 15 of 17

17 Where you think that the policy has no impact on any of the equality group(s) listed below i.e. it has no effect currently on equality groups, tick the No impact box. Equality Group Age Disability Religion or belief Gender Transgender Pregnancy/ Maternity Race Sexual Orientation Marriage / Civil Partnership Positive Impact Negative Impact No Impact Reasons for decision You will need to continue to a full Equality Impact Assessment if the following have been highlighted: A negative impact and No consultation (this excludes any policies which have been identified as not requiring consultation). 8. If there is no evidence that the policy promotes equality, equal opportunities or improved relations - could it be adapted so that it does? How? Full statement of commitment to policy of equal opportunities is included in the policy Please sign and date this form. Keep one copy and send a copy to Matron, Equality, Diversity and Human Rights, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Chyvean House, Penventinnie Lane, Truro, Cornwall, TR1 3LJ A summary of the results will be published on the Trust s web site. Signed Date Page 16 of 17

Diagnostic Testing Procedures in Urodynamics V3.0

Diagnostic Testing Procedures in Urodynamics V3.0 V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.

More information

Diagnostic Testing Procedures for Ophthalmic Science

Diagnostic Testing Procedures for Ophthalmic Science V4.0 01/08/17 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the Managers... 3 5.3.

More information

Diagnostic Testing Procedures in Neurophysiology V1.0

Diagnostic Testing Procedures in Neurophysiology V1.0 V1.0 10 September 2012 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the

More information

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.

More information

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist. 1. Aim/Purpose of this Guideline 1.1 This protocol applies to upper & lower GI Non medical Endoscopist

More information

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department. Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist

More information

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays. Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Endoscopist (Lower GI) within the Royal Cornwall Hospitals Trust 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse

More information

Tissue Viability Referral Pathway. April 2017

Tissue Viability Referral Pathway. April 2017 Tissue Viability Referral Pathway V4 April 2017 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...

More information

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start The non-medical practitioner has received sufficient training to make clinical

More information

School Vision Screening Policy V2.0

School Vision Screening Policy V2.0 School Vision Screening Policy V2.0 05 April 2016 Summary. Vision screening test in school PASS Visual acuity LogMAR 0.2 both eyes Kays 0.1 both eyes Outcome letter sent home Test result information put

More information

Policy on Governance Arrangements Relating to Medicines V2.0

Policy on Governance Arrangements Relating to Medicines V2.0 V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters

More information

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 January 2016 Summary. This policy applies only to selected staff within the Haematology Department at the

More information

Loading Dose Worksheet for Oral Amiodarone

Loading Dose Worksheet for Oral Amiodarone This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.

More information

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL GUIDELINE V4. Summary. Start The non-medical practitioner

More information

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide anaesthetists with an algorithm to work with when dealing with

More information

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline To provide guidance for appropriate referral to the acute pain service for in-patient review. 2. The Guidance PAIN SERVICES

More information

Newborn Hearing Screening Programme Policy

Newborn Hearing Screening Programme Policy Newborn Hearing Screening Programme Policy V3.0 December 2015 Page 1 of 16 Summary - Screening Pathway for Newborn Hearing Screening Newborn hearing screening Check eligibility Eligible for screening Not

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline aims to improve outcomes for patients presenting with sepsis or developing sepsis

More information

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) 1. Aim/Purpose of this Guideline 1.1. Pain is whatever the experiencing person says it is, existing whenever the experiencing person

More information

CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of for the management of Adult patients with Mellitus

More information

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline This guideline is to support the use of bed and chair sensor alarm

More information

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite ADVANCED NEONATAL NURSE PRACTITIONERS (ANNPs) BLOOD COMPONENT AND BLOOD PRODUCT REQUESTING PROTOCOL NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 The purpose of this protocol is to guide

More information

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and

More information

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its

More information

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy

More information

The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0

The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 October 2016 Summary. Start See section 6.2 of this document for important information regarding

More information

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical

More information

WARD CLOSURE POLICY V

WARD CLOSURE POLICY V WARD CLOSURE POLICY V3.0 29.07.15 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 4 5.1.

More information

Safe Bathing Policy V1.3

Safe Bathing Policy V1.3 V1.3 April 2018 Summary Safe hot water temperatures The hot water distribution temperatures, which are required for the control and prevention of Legionella, can lead to discharge temperatures in excess

More information

Management of Diagnostic Testing and Screening Procedures Policy

Management of Diagnostic Testing and Screening Procedures Policy Trust Policy Management of Diagnostic Testing and Screening Procedures Policy Purpose Date Version July 2012 2 The purpose of this policy is to ensure that all diagnostic and screening tests undertaken

More information

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its

More information

2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.

2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures. Was Not Brought, Cancellation and Refusal of Appointments Policy for Children and Young People up to the Age of 18 Years (up to the age of 25 years for people with a Learning Disability) 1. Aim/Purpose

More information

Patient Experience Strategy

Patient Experience Strategy POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 Page 1 of 13 Abbreviation (P/A)HDU (P/A)ICU GCS IPPV CPAP BiPAP DKA Reg Meaning (Paediatric/Adult) High Dependency

More information

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin. CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing

More information

ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline

ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline 1.1. This guidance is designed to aid staff to monitor capacity and staffing in Child Health. 2. The Guidance 2.1. The majority

More information

Safeguarding Children Supervision Policy V4.0. November 2016

Safeguarding Children Supervision Policy V4.0. November 2016 Safeguarding Children Supervision Policy V4.0 November 2016 Page 1 of 20 Summary Part 1 Part 2 Safeguarding supervision for Nursing and Midwifery staff, Paediatricians, Medical Staff and other Allied Health

More information

Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives

Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives NHS Dorset Clinical Commissioning Group Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives PREFACE This Document outlines the CCG s policy in respect

More information

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY (To be read in conjunction with Diagnostic Imaging Requesting and Interpreting Radiographs by Non Medical Practitioners Policy, Consent

More information

Author: Kelvin Grabham, Associate Director of Performance & Information

Author: Kelvin Grabham, Associate Director of Performance & Information Trust Policy Title: Access Policy Author: Kelvin Grabham, Associate Director of Performance & Information Document Lead: Kelvin Grabham, Associate Director of Performance & Information Accepted by: RTT

More information

ORAL ANTI-CANCER THERAPY POLICY

ORAL ANTI-CANCER THERAPY POLICY ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive

More information

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:

More information

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified

More information

Provision of Wigs Policy

Provision of Wigs Policy Post holder responsible for Procedural Document Author and post holder of Policy Division/Department responsible for Procedural Document Contact details Lead Cancer Nurse Tina Grose, Lead Cancer Nurse

More information

Occupational Health Surveillance Policy V2.1

Occupational Health Surveillance Policy V2.1 Occupational Health Surveillance Policy V2.1 May 2016 Table of Contents 1. Introduction... 2 2. Purpose of this Policy... 2 3. Scope... 2 4. Definitions/Glossary... 3 5. Ownership and Responsibilities...

More information

Document Title: Study Data SOP (CRFs and Source Data)

Document Title: Study Data SOP (CRFs and Source Data) Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY

NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY PLEASE NOTE POLICY IS UNDER REVIEW NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY Target Audience Brief Description (max 50 words) Action Required Providers, Commissioners

More information

POLICY FOR X RAY REFERRAL BY QUALIFIED NURSE PRACTITIONERS WORKING IN GENERAL PRACTICE

POLICY FOR X RAY REFERRAL BY QUALIFIED NURSE PRACTITIONERS WORKING IN GENERAL PRACTICE POLICY FOR X RAY REFERRAL BY QUALIFIED NURSE PRACTITIONERS WORKING IN GENERAL PRACTICE APPROVED BY: Chief Nurse May 2016 EFFECTIVE FROM: May 2016 REVIEW DATE: May 2018 Version Control Policy Category:

More information

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines Document Number Version Ratified By & Date Name of Approving Body(s) & Date(s) FPE-004 V1 Safety and Effectiveness Sub-Committee

More information

OXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0

OXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 OYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline 1.1 To provide guidance on the assessment and management of infants requiring oxygen therapy

More information

Document Title: Recruiting Process. Document Number: 011

Document Title: Recruiting Process. Document Number: 011 Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

Seven Day Services Clinical Standards September 2017

Seven Day Services Clinical Standards September 2017 Seven Day Services Clinical Standards September 2017 11 September 2017 Gateway reference: 06408 Patient Experience 1. Patients, and where appropriate families and carers, must be actively involved in shared

More information

Procedure for the Application of a Cast and its subsequent care V1.3

Procedure for the Application of a Cast and its subsequent care V1.3 Procedure for the Application of a Cast and its subsequent care V1.3 May 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary...

More information

Other (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications

Other (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Judy Potter, Lead Nurse, Infection Prevention & Control Judy Potter,

More information

Policy Summary. Policy Title: Policy and Procedure for Clinical Coding

Policy Summary. Policy Title: Policy and Procedure for Clinical Coding Policy Title: Policy and Procedure for Clinical Coding Reference and Version No: IG7 Version 6 Author and Job Title: Caroline Griffin Clinical Coding Manager Executive Lead - Chief Information and Technology

More information

Trust Policy Access Policy For Planned Care Services

Trust Policy Access Policy For Planned Care Services Trust Policy Access Policy For Planned Care Services Purpose Date Version July 2015 2 To inform staff of the key principles for managing patients on an Elective waiting List. Who should read this document?

More information

MULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY

MULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY MULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY (To be read in conjunction with Handover Policy) Version: 3 Ratified by: Date ratified: August 2015 Title of originator/author: Title of responsible

More information

Implementation of the right to access services within maximum waiting times

Implementation of the right to access services within maximum waiting times Implementation of the right to access services within maximum waiting times Guidance for strategic health authorities, primary care trusts and providers DH INFORMATION READER BOX Policy HR / Workforce

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017

More information

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed: Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy

More information

Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0

Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 January 2016 Summary Purpose of the document: The purpose of this policy is to provide an outline of the requirements

More information

Quality Manual. Folder One

Quality Manual. Folder One Section: Front page Bowel Screening Wales Quality Manual Folder One Version 2.0 If printed, this document is only valid for today 05 Page 1 of Section: Contents 1. Introduction... 4 2. Aim and Scope of

More information

NHS. Top tips to overcome the challenge of commissioning diagnostic services. NHS Improvement - Diagnostics. NHS Improvement Diagnostics CANCER

NHS. Top tips to overcome the challenge of commissioning diagnostic services. NHS Improvement - Diagnostics. NHS Improvement Diagnostics CANCER CANCER NHS NHS Improvement Diagnostics DIAGNOSTICS HEART LUNG STROKE NHS Improvement - Diagnostics Top tips to overcome the challenge of commissioning diagnostic services Top tips to overcome the challenge

More information

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Document Title: GCP Training for Research Staff. Document Number: SOP 005 Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:

More information

ACCESS TO HEALTH RECORDS POLICY & PROCEDURE

ACCESS TO HEALTH RECORDS POLICY & PROCEDURE ACCESS TO HEALTH RECORDS POLICY & PROCEDURE Document Number 2009/45 Version 3 Document Title Access to Health Records Policy & Procedure Author Karl Perryman Author s Job Title Head of Legal Services Department

More information

Policy for Patient Access

Policy for Patient Access Policy for Patient Access DOCUMENT CONTROL Revision Date Old Version 10/12/2014 1.0 01/07/2016 1.1 30/04/17 1.2 Amendment General Management Review General Management Review General Management Review Authored

More information

CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND

CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND 1. Aim/Purpose of this Guideline The aim of this guideline to enable the effective care of patients needing emergency defill of

More information

Referral to Treatment (RTT) Access Policy

Referral to Treatment (RTT) Access Policy General Referral to Treatment (RTT) Access Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive is the controlled copy.

More information

MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 This guideline aimed at all clinical staff responsible for the management of infants

More information

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST. PATIENT ACCESS MANAGEMENT POLICY (Previously known as Waiting List Management Policy) Documentation Control

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST. PATIENT ACCESS MANAGEMENT POLICY (Previously known as Waiting List Management Policy) Documentation Control NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST PATIENT ACCESS MANAGEMENT POLICY (Previously known as Waiting List Management Policy) Documentation Control Reference CL/CGP/026 Approving Body Senior Management

More information

Safe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017

Safe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017 Safe Staffing Levels for Midwifery, Nursing and Support Staff For Maternity Service - Approved V1.5 June 2017 Jan Walters Head of Midwifery Women, Children and Sexual Health Division CONTENTS Section Page

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of

More information

Central Alerting System (CAS) Policy

Central Alerting System (CAS) Policy Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray

More information

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline

More information

National Waiting List Management Protocol

National Waiting List Management Protocol National Waiting List Management Protocol A standardised approach to managing scheduled care treatment for in-patient, day case and planned procedures January 2014 an ciste náisiúnta um cheannach cóireála

More information

MORTALITY REVIEW POLICY

MORTALITY REVIEW POLICY MORTALITY REVIEW POLICY Version 1.3 Version Date July 2017 Policy Owner Medical Director Author Associate Director of Patient Safety & Quality First approval or date last reviewed July 2017 Staff/Groups

More information

Register No: Status: Public on ratification

Register No: Status: Public on ratification Private Patient Policy Type: Policy Register No: 12024 Status: Public on ratification Developed in response to: Service Development Contributes to CQC Outcome number: 4 Consulted With Post/Committee/Group

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical

More information

Medical Devices Management Policy

Medical Devices Management Policy Medical Devices Management Policy Document Reference Document Status POL025 Version: V2.0 Approved DOCUMENT CHANGE HISTORY Initiated by Date Author (s) 20 May 2015 Richard Kirk Version Date Comments (i.e.

More information

Delegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers. Version No.1 Review: November 2019

Delegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers. Version No.1 Review: November 2019 Livewell Southwest Delegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers Version No.1 Review: November 2019 Notice to staff using a paper copy of this guidance

More information

Patient Experience Strategy

Patient Experience Strategy Patient Experience Strategy 2013 2018 V1.0 May 2013 Graham Nice Chief Nurse Putting excellent community care at the heart of the NHS Page 1 of 26 CONTENTS INTRODUCTION 3 PURPOSE, BACKGROUND AND NATIONAL

More information

Unique Identifier: Review Date: November Issue Status: Approved Version No: 1.4 Issue Date: November 2017

Unique Identifier: Review Date: November Issue Status: Approved Version No: 1.4 Issue Date: November 2017 Policy Authors Name & Title: Dr Mark Jackson, Director of Research & Informatics Dr Raphael Perry, Medical Director Scope: Trust Wide Classification: Non Clinical Replaces: version 1.3 To be read in conjunction

More information

Commissioning Policy

Commissioning Policy Commissioning Policy Consultant to Consultant Referrals Version 6.0 December 2017 Name of Responsible Board / Committee for Ratification: North Staffordshire CCG Stoke on Trent CCG Date Issued: November

More information

NON-MEDICAL PRESCRIBING POLICY

NON-MEDICAL PRESCRIBING POLICY NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August

More information

Referral for Imaging by Non-Medical Staff Policy

Referral for Imaging by Non-Medical Staff Policy Medical Imaging Service Referral for Imaging by Non-Medical Staff Policy This procedural document supersedes: PAT/T 1 v.3 - Medical Imaging Clinical Service Unit Referral for Imaging by Non-Medical Staff

More information

Manual Handling Policy

Manual Handling Policy Manual Handling Policy Document Information This is a controlled document. It should not be altered in any way without the express permission of the author or their representative. On receipt of a new

More information

Version Number Date Issued Review Date V1: 28/02/ /08/2014

Version Number Date Issued Review Date V1: 28/02/ /08/2014 Corporate CCG CO01 Access and Choice Policy Version Number Date Issued Review Date V1: 28/02/2013 31/08/2014 Prepared By: Consultation Process: Governance Lead, NHS South of Tyne and Wear Information Governance

More information

62 days from referral with urgent suspected cancer to initiation of treatment

62 days from referral with urgent suspected cancer to initiation of treatment Appendix-2012-87 Borders NHS Board PATIENT ACCESS POLICY Aim In preparation for the introduction of the Patients Rights (Scotland) Act 2011, NHS Borders has produced a Patient Access Policy governing the

More information

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation

More information

PATIENT ACCESS POLICY

PATIENT ACCESS POLICY PATIENT ACCESS POLIC Document Reference No. CORP002v9.9 Version No. 9.9 Issue Date June 2017 Review Date March 2020 Document Author Head of Access, Booking & Choice Document Owner Accountable Executive

More information

Consultant to Consultant Referral Policy

Consultant to Consultant Referral Policy Consultant to Consultant Referral Policy Version Author Date Comments Approved by No V1.0 Mel Sims 19 January 2017 To be APPROVED Governing Body Reader information Reference Document purpose COM002 This

More information

Document Management Section (if applicable) Previous policy number NA Previous version

Document Management Section (if applicable) Previous policy number NA Previous version Policy Title Patient Access Policy Version Policy Number 0059 5 number All administrative / clerical / managerial staff Applicable to involved in the administration of patient pathway. All medical and

More information

GCP Training for Research Staff. Document Number: 005

GCP Training for Research Staff. Document Number: 005 GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS

CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,

More information

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: PROVISION OF INFORMATION TO DETAINED PATIENTS Document Author Written By: Lead for Mental Health

More information

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE EQUALITY IMPACT The Trust strives to ensure equality and opportunity for all, both as a major employer and as a provider of health care. This policy

More information

Committee is requested to action as follows: Richard Walker. Dylan Williams

Committee is requested to action as follows: Richard Walker. Dylan Williams BetsiCadwaladrUniversityHealthBoard Committee Paper 17.11.14 Item IG14_60 NameofCommittee: Subject: Summary or IssuesofSignificance StrategicTheme/Priority / Valuesaddressedbythispaper Information Governance

More information

LEARNING FROM DEATHS POLICY

LEARNING FROM DEATHS POLICY Issue number: 1st Edition LEARNING FROM DEATHS POLICY Author with contact details Dr Neil Mercer, Associate Medical Director for Clinical Governance Neil.mercer@aintree.nhs.uk tel. 529-5152 Original Issue

More information

CARERS POLICY. All Associate Director of Patient Experience. Patient & Carers Experience Committee & Trust Management Committee

CARERS POLICY. All Associate Director of Patient Experience. Patient & Carers Experience Committee & Trust Management Committee CARERS POLICY Department / Service: Originator: All Associate Director of Patient Experience Accountable Director: Chief Nursing Officer Approved by: Patient & Carers Experience Committee & Trust Management

More information